Thomas Carrigan, MD
Clinical Cardiac Electrophysiology · Edgewood, KYNPI 1912178641
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (40.3%), travel and lodging and consulting fees — rather than concentrated in one kind of arrangement. 23 manufacturers reported payments, led by Boston Scientific at 24.2% of the total. Reporting peaked in 2022 at $5,621 and has fallen 65.2% since, to $1,954 in 2025. That places this record below the midpoint for clinical cardiac electrophysiology clinicians in KY, where the typical reported total is $16,637.
Across 144 payments — averaging $114.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$4K
- Biotronik Inc.$3K
- Volta Medical Inc$3K
- Abbott$2K
- Biosense Webster, Inc.$2K
- Medtronic$1K
- plus $1K from 17 others
Across 3 payments — averaging $4500.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Medtronic$8K
- Medical Device Business Services, Inc.$6K
What the payments were for
- Consulting fees$3,25020%
- Speaking & faculty fees$3,09819%
- Travel & lodging$3,51721%
- Food & beverage$6,64940%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 35 | $3,995 |
| Biotronik Inc. | 1 | $3,250 |
| Volta Medical Inc | 12 | $3,135 |
| Abbott | 12 | $2,163 |
| Biosense Webster, Inc. | 35 | $1,543 |
| Medtronic(3 entities) | 12 | $1,097 |
| Edwards Lifesciences | 2 | $209 |
| Boehringer Ingelheim | 3 | $154 |
| Pfizer | 10 | $150 |
| E.r. Squibb & Sons, L.L.C. | 3 | $142 |
| Merit Medical Systems Inc | 1 | $106 |
| ZOLL Respicardia, Inc. | 1 | $105 |
| Cvrx, Inc. | 2 | $102 |
| Cardiofocus, Inc. | 2 | $101 |
| Amgen | 4 | $72 |
| Cardiva Medical, Inc. | 1 | $49 |
| Cordis US CORP. | 1 | $33 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 2 | $28 |
| Portola Pharmaceuticals, LLC | 1 | $27 |
| Bayer | 1 | $17 |
| Kiniksa Pharmaceuticals International, PLC | 1 | $14 |
| Angiodynamics, Inc. | 1 | $12 |
| Itamar Medical Inc | 1 | $10 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Protego$3,250
- VX1$2,870
- GENERAL - THERAPIES$1,295
- AVEIR$1,144
- Carto 3$841
- WATCHMAN Access System$706
- AMPLATZER TORQVUE 45 X 45$390
- AMPLATZER AMULET$370
- AURORA EV-ICD MRI SURESCAN$263
- RHYTHMIA$245
- PulseSelect$210
- SAPIEN 3 Ultra RESILIA$204
- ENSITE PRECISION$163
- Advisa$145
- COREVALVE EVOLUT R$144
- DYNAGEN$141
- RESONATE EL ICD VR$132
- COBALT DR MRI SURESCAN$132
- RESONATE$131
- Carto 3 System$122
How this compares
$16,514 in reported general payments places this provider in the 45th percentile of 57 clinical cardiac electrophysiology providers in Kentucky.
See all clinical cardiac electrophysiology providers in Kentucky →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 348 | $299,495 |
| XareltoRivaroxaban | 45 | $48,717 |
| MultaqDronedarone Hcl | 12 | $18,266 |
| Diltiazem 12hr ErDiltiazem Hcl | 18 | $7,680 |
| Metoprolol Succinate | 340 | $4,757 |
| SotalolSotalol Hcl | 248 | $4,348 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 100 | $2,664 |
| Amiodarone Hcl | 144 | $2,270 |
| Propafenone Hcl ErPropafenone Hcl | 11 | $2,156 |
| Dabigatran EtexilateDabigatran Etexilate Mesylate | 11 | $1,654 |
| Flecainide Acetate | 12 | $538 |
| Pantoprazole Sodium | 19 | $263 |
| Metoprolol Tartrate | 68 | $245 |
| Warfarin Sodium | 20 | $113 |
| Carvedilol | 16 | $109 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $150 | $299,495348 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 45th percentile of 57 clinical cardiac electrophysiology providers in Kentucky.
Other clinical cardiac electrophysiology in Edgewood
- Konstantinos KossidasEdgewood$32K
- Mohamad SinnoEdgewood$14K
- Jon HaysEdgewood$5K
- Johan AasboLexington$451K
- Rajdeep GaitondeLouisville$404K
- Jeffrey StidamLouisville$196K
- Gery TomassoniLexington$196K
- Kent MorrisLouisville$187K
- John LeeLexington$139K
- Joseph SouzaLexington$110K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.